We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...

With just hours before the Oscars, the question on everyone’s mind is how are people achieving flawless, red carpet–ready ...

AstraZeneca, a global, science-led biopharmaceutical company, has made available its treatment, Soliris®, in Malaysia as part of its ongoing ...

MassLive and The Republican spent nine months investigating what spurred the Mass. DOC's highest number of suicides in years.

When David Thau, a lobbyist in Washington, D.C., was 34, he periodically experienced pain in his stomach, irregular bowel movements, blood in his stool and vomiting, and he visited doctors ...

An Ottawa doctor and scientist, whose first-in-Canada trial of a novel way of treating lethal artificial joint infections ...

A 2026 Supreme Court ruling allows withdrawal of life support in the Harish Rana case, testing India’s right-to-die jurisprudence and exposing the need for legislation.

The mass detention of Uyghurs in Xinjiang has evolved since 2008, particularly escalating after 2014 and dramatically intensifying from 2017. This system, described as the largest internment network ...

Researchers have found statistically significant links between a gene tied to schizophrenia risk and poorer cognitive ...

The Collection de l’Art Brut in Lausanne is turning 50 – and is marking the occasion with an exhibition, taking visitors back to the early days, when art created in psychiatric clinics went unseen for ...

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

Longevity and AI experts discuss the bottlenecks preventing AI-driven insights from becoming actionable clinical interventions.